Based on the ATS and IDSA guidelines for ATM lung disease, what clinical symptomatology, microbiologic evidence, and/or radiographic findings should alert the clinician that the diagnosis of MAC lung disease should be considered?

Based on the ATS and IDSA guidelines for ATM lung disease, what clinical symptomatology, microbiologic evidence, and/or radiographic findings should alert the clinician that the diagnosis of MAC lung disease should be considered?

Based on the ATS and IDSA guidelines for ATM lung disease, what clinical symptomatology, microbiologic evidence, and/or radiographic findings should alert the clinician that the diagnosis of MAC lung disease should be considered?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Patrick Flume, MD

Patrick Flume, MD

Professor of Medicine and Pediatrics
Medical University of South Carolina
Powers-Huggins Endowed Chair for Cystic Fibrosis
University of South Carolina
Charleston, South Carolina